RxDoctor Payments Data

Narendra Reddy, MD

Psychiatry · Omaha, NENPI 1649320649

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.3% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $585 and has fallen 96.2% since, to $22 in 2025.

$1,073in general payments, 2019–2025

Across 66 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$180
  • Otsuka America Pharmaceutical, Inc.$177
  • Johnson & Johnson$174
  • Sunovion Pharmaceuticals Inc.$88
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$75
  • Bausch Health US, LLC$58
  • plus $322 from 11 others

What the payments were for

  • Food & beverage$99092%
  • Education$838%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,073 in reported general payments places this provider in the 75th percentile of 160 psychiatry providers in Nebraska.

See all psychiatry providers in Nebraska

Medicare billing

Part B allowed, 2024
$3,959
Medicare patients
12
Services billed
37

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole32$3,005
Duloxetine Hcl33$939
Lamotrigine26$703
Bupropion XlBupropion Hcl31$678
Trazodone Hcl33$621
Divalproex Sodium14$605
Escitalopram Oxalate53$557
Sertraline Hcl40$529
Quetiapine Fumarate40$423
Clonazepam46$349
Mirtazapine14$338
Paroxetine Hcl15$326
Bupropion Hcl SrBupropion Hcl19$309
Alprazolam56$280
Gabapentin14$261

Paid to pharmacies, not to this prescriber.

Other psychiatry in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →